NCT01972477 - DLBS1449 in Diabetic Patients With Low HDL | Biotech Hunter

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

January 31, 2018

Conditions

Diabetic PatientsLow HDL-cholesterol (< 35 mg/dL)Lifestyle Intervention for at Least 1 Month

Interventions

DRUG

DLBS1449

Study treatment will be DLBS1449 softcapsules at a dose of 1x75 mg daily or DLBS1449 at a dose of 1x150 mg daily. DLBS1449 will be given every day for 8 weeks.

OTHER

Placebo

Placebo will be given every day for 8 weeks.

Trial Locations (1)

Unknown

Surabaya Diabetes and Nutrition Center, Dr. Soetomo Hospital; Pusat Diagnostik Terpadu Building 7th Floor, Surabaya